FTC Approves Sale of Gambro Unit to DaVita
From Bloomberg News
DaVita Inc., a provider of dialysis services for kidney patients, said the Federal Trade Commission had approved its purchase of Gambro Healthcare Inc., with a requirement that it sell 70 dialysis centers.
DaVita expects to complete the $3.1-billion cash purchase of the U.S. unit of Stockholm-based Gambro early this month.
El Segundo-based DaVita must sell 67 dialysis centers within 10 days and three centers within 60 days of the completion of the acquisition.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
